Endometrial polyps and associated factors in Danish women aged 36-74 years.

[1]  L. Mollamahmutoğlu,et al.  Body mass index is an independent risk factor for the development of endometrial polyps in patients undergoing in vitro fertilization. , 2009, Fertility and sterility.

[2]  E. Baracat,et al.  Analysis of estrogen- and progesterone-receptor expression in endometrial polyps. , 2007, Journal of minimally invasive gynecology.

[3]  S. Duffy,et al.  Are endometrial polyps from pre-menopausal women similar to post-menopausal women? An immunohistochemical comparison of endometrial polyps from pre- and post-menopausal women. , 2006, Maturitas.

[4]  I. Fraser,et al.  Hormone Receptor Expressions and Proliferation Markers in Postmenopausal Endometrial Polyps , 2006, Gynecologic and Obstetric Investigation.

[5]  J. Costantino,et al.  Benign gynecologic conditions among participants in the Breast Cancer Prevention Trial. , 2005, American journal of obstetrics and gynecology.

[6]  H. Aytan,et al.  The role of hormone replacement therapy in endometrial polyp formation. , 2005, Maturitas.

[7]  S. Zucoloto,et al.  Immunohistochemical expression of estrogen and progesterone receptors in endometrial polyps and adjacent endometrium in postmenopausal women. , 2004, Maturitas.

[8]  N. Rojansky,et al.  How Often Are Endometrial Polyps Malignant? , 2004, Gynecologic and Obstetric Investigation.

[9]  Z. Hagay,et al.  The malignant potential of endometrial polyps. , 2004, European journal of obstetrics, gynecology, and reproductive biology.

[10]  I. Cohen.  Endometrial pathologies associated with postmenopausal tamoxifen treatment. , 2004, Gynecologic oncology.

[11]  H. Maia,et al.  Effect of previous hormone replacement therapy on endometrial polyps during menopause , 2004, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[12]  H. Lashen,et al.  The value of outpatient hysteroscopy in diagnosing endometrial pathology in postmenopausal women with and without hormone replacement therapy , 2003, Acta obstetricia et gynecologica Scandinavica.

[13]  C. Castelo-Branco,et al.  Tibolone and risk of endometrial polyps: a prospective, comparative study with hormone therapy , 2003, Menopause.

[14]  Charlotte Glümer,et al.  A randomized non-pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99 (1) , 2003, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[15]  S. Duffy,et al.  The differential expression of oestrogen receptors, progesterone receptors, Bcl‐2 and Ki67 in endometrial polyps , 2003, BJOG : an international journal of obstetrics and gynaecology.

[16]  D. Timmerman,et al.  Ultrasound assessment of endometrial thickness and endometrial polyps in women on hormonal replacement therapy. , 2003, American journal of obstetrics and gynecology.

[17]  Elettra Pignotti,et al.  Histopathologic features and risk factors for benignity, hyperplasia, and cancer in endometrial polyps. , 2003, American journal of obstetrics and gynecology.

[18]  I. Nofroni,et al.  Hysteroscopic findings in postmenopausal abnormal uterine bleeding: a comparison between HRT users and non-users. , 2002, Maturitas.

[19]  William A. Davis,et al.  Natural History of Uterine Polyps and Leiomyomata , 2002, Obstetrics and gynecology.

[20]  J. Gupta,et al.  Risk factors associated with endometrial polyps in abnormal uterine bleeding , 2002, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[21]  J. Bar,et al.  Endometrial polyps during menopause, characterization and significance , 1999, Acta obstetricia et gynecologica Scandinavica.

[22]  H. Maia,et al.  Hysteroscopy and transvaginal sonography in menopausal women receiving hormone replacement therapy. , 1996, The Journal of the American Association of Gynecologic Laparoscopists.

[23]  A. Garratt,et al.  Assessment of patients with menorrhagia: How valid is a structured clinical history as a measure of health status? , 1995, Quality of Life Research.

[24]  T. Bourne,et al.  Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial , 1994, The Lancet.

[25]  R. Campo,et al.  Hysteroscopic findings in patients with a cervical polyp. , 1993, American journal of obstetrics and gynecology.

[26]  J. Deprest,et al.  Endometrial polyp: another benign tumor characterized by 12q13-q15 changes. , 1993, Cancer genetics and cytogenetics.

[27]  P. Cin,et al.  The 6p21 chromosome region is nonrandomly involved in endometrial polyps. , 1992, Gynecologic oncology.

[28]  J. R. Landis,et al.  The measurement of observer agreement for categorical data. , 1977, Biometrics.

[29]  L. Valentin.  Prevalence of endometrial polyps and abnormal uterine bleeding in a Danish population aged 20-74 years. , 2009 .

[30]  G. Kourounis,et al.  Is dosage of hormone replacement therapy related with endometrial polyp formation? , 2006, European journal of gynaecological oncology.

[31]  Peter Devilee,et al.  Pathology and Genetics of Tumours of the Breast and Female Genital Organs , 2003 .

[32]  Cdm Fletcher,et al.  World Health Organization Classification of Tumours , 2002 .

[33]  P. Anastasiadis,et al.  Descriptive epidemiology of endometrial hyperplasia in patients with abnormal uterine bleeding. , 2000, European journal of gynaecological oncology.

[34]  J. Tošner,et al.  Endometrial polyps , 1999, Archives of Gynecology and Obstetrics.

[35]  F. Reis,et al.  Cervical polyp as risk factor for hysteroscopically diagnosed endometrial polyps. , 1997, Gynecologic and obstetric investigation.